A

Akero Therapeutics (AKRO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Akero Therapeutics (AKRO)

Akero Therapeutics Inc. is a cardio-metabolic non-alcoholic steatohepatitis (NASH) company. The Company is focused on developing medicines designed to restore metabolic balance and improve the overall health of patients with NASH. Its lead product ca... Read more

  • USD49.08
  • USD49.08
  • USD46.49
  • USD54.88
  • -2.50%
  • --
  • 165.00
  • 656.03k
  • 2.2B
  • 7.52
  • 161.00%

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.